Literature DB >> 9441701

Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses.

V M Elner1, M A Burnstine, R M Strieter, S L Kunkel, S G Elner.   

Abstract

Human retinal pigment epithelial (RPE) cells secrete chemokines, interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) in response to pro-inflammatory cytokines. In this study we (1) examined the efficiency of human RPE IL-8 and MCP-1 secretion, (2) determined the amount of neutrophil and monocyte chemotactic activity in human RPE cell conditioned media and cell extracts that is attributable to IL-8 and MCP-1, respectively, and (3) assessed the sensitivity of immunohistochemistry and in situ hybridization for detecting chemokine production by cytokine-stimulated human RPE cells. Conditioned media and extracts from human RPE cells stimulated with various physiologic concentrations of interleukin-1 beta (IL-1 beta) (0.2-20 ng ml-1), tumor necrosis factor (TNF-alpha) (0.2-20 ng ml-1) or interferon-gamma (IFN-gamma) (10-1000 U ml-1) were examined to compare secreted and cell associated levels of IL-8 and MCP-1 at various time points up to 24 hr. ELISA demonstrated that IL-8 and MCP-1 are both efficiently secreted by pro-inflammatory cytokine treated human RPE cells. Substantial dose- and time-dependent RPE secretion of IL-8 was observed following stimulation with IL-1 beta or TNF-alpha, but cell associated IL-8 was detectable only after high dose (20 ng ml-1) IL-1 beta stimulation and comprised less than 1% of the total IL-8 induced. Dose- and time-dependent RPE cell MCP-1 secretion was also observed following IL-1 beta > TNF-alpha > IFN-gamma stimulation, with an average of 4% of the total MCP-1 retained within RPE. Bioassays demonstrated neutrophil and monocyte chemotactic activity in conditioned media from stimulated RPE cells, but not in human RPE cell extracts. Inhibition of conditioned media-induced chemotaxis by specific anti-IL-8 or anti-MCP-1 antibodies demonstrated that IL-8 and MCP-1 were responsible for the majority of HRPE-derived neutrophil (> 60%) and monocyte (53-57%) chemotactic activity, respectively. Using in situ hybridization IL-8 mRNA was readily detected within IL-1 beta > TNF-alpha stimulated RPE cells and MCP-1 mRNA easily visualized within IL-1 beta > TNF-alpha > or IFN-gamma stimulated cells. Immunohistochemistry to detect IL-8 was positive only in RPE cells exposed to high dose IL-1 beta (20 ng ml-1) for 8 or 24 hr and was weak. Immunohistochemical staining for MCP-1 in RPE cells was more intense and was visualized within RPE cells stimulated with IL-beta, TNF-alpha, or IFN-gamma. This study demonstrates that: (1) RPE cells efficiently secrete IL-8 and MCP-1 upon stimulation with pro-inflammatory cytokines; (2) secreted IL-8 and MCP-1 account for the majority of human RPE neutrophil and monocyte chemotactic activity; (3) in situ hybridization readily detects IL-8 and MCP-1 mRNA in cytokine stimulated RPE cells; and (4) immunohistochemistry demonstrates cell-associated MCP-1 in cytokine stimulated RPE cells, but only minimal cell-associated IL-8.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441701     DOI: 10.1006/exer.1997.0380

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  27 in total

1.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells.

Authors:  Qingning Bian; Shasha Gao; Jilin Zhou; Jian Qin; Allen Taylor; Elizabeth J Johnson; Guangwen Tang; Janet R Sparrow; Dennis Gierhart; Fu Shang
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

3.  Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.

Authors:  Long V Ly; Inge H G Bronkhorst; Els van Beelen; Johannes Vrolijk; Andrew W Taylor; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

4.  Early focal expression of the chemokine Ccl2 by Müller cells during exposure to damage-inducing bright continuous light.

Authors:  Matt Rutar; Riccardo Natoli; Krisztina Valter; Jan M Provis
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-12       Impact factor: 4.799

5.  Neutrophils compromise retinal pigment epithelial barrier integrity.

Authors:  Jiehao Zhou; Shikun He; Ning Zhang; Christine Spee; Peng Zhou; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  J Biomed Biotechnol       Date:  2010-03-03

6.  Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells.

Authors:  Dongli Yang; Susan G Elner; Zong-Mei Bian; Gerd O Till; Howard R Petty; Victor M Elner
Journal:  Exp Eye Res       Date:  2007-06-27       Impact factor: 3.467

7.  HSV keratitis: histopathologic predictors of corneal allograft complications.

Authors:  Roni M Shtein; Denise D Garcia; David C Musch; Victor M Elner
Journal:  Trans Am Ophthalmol Soc       Date:  2008

8.  Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina.

Authors:  Xi-Qin Ding; Alexander B Quiambao; J Browning Fitzgerald; Mark J Cooper; Shannon M Conley; Muna I Naash
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

9.  Effect of TNF-alpha on human ARPE-19-secreted proteins.

Authors:  Eunkyung An; Heather Gordish-Dressman; Yetrib Hathout
Journal:  Mol Vis       Date:  2008-12-11       Impact factor: 2.367

10.  Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.

Authors:  Muhammad A Ahad; Tom Missotten; Atiyeh Abdallah; Penny A Lympany; Susan Lightman
Journal:  Mol Vis       Date:  2007-03-23       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.